参考文献/References:
[1]Anderson JL,Morrow DA.Acute Myocardial Infarction[J].N Engl J Med,2017,376(21):2053-2064.[2]Zeymer U.Diagnosis and initial management of acute myocardial infarction[J].MMW Fortschr Med,2019,161(4):34-36.[3]Fan J,Ma J,Xia N,et al.Clinical Value of Combined Detection of CK-MB,MYO,cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction [J].Clin Lab,2017,63(3):427-433.[4]Wang C,Jing Q.Non-coding RNAs as biomarkers for acute myocardial infarction [J].Acta Pharmacol Sin,2018,39(7):1110-1119.[5]Zhai C,Li R,Hou K,et al.Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction:A Systematic Review and Meta-Analysis[J].Front Physiol,2020(11):691.[6]Matboli M,Shafei AE,Agwa SHA,et al.Identification of Novel Molecular Network Expression in Acute Myocardial Infarction[J].Curr Genomics,2019,20(5):340-348.[7]Wang Q,Liu B,Wang Y,et al.The biomarkers of key miRNAs and target genes associated with acute myocardial infarction[J].Peer J,2020,8(17):9129[8]Zhong Z,Wu H,Zhong W,et al.Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction[J].J Clin Lab Anal,2020,34(3):23099.[9]Wang X,Tian L,Sun Q.Diagnostic and prognostic value of circulating miRNA-499 and miRNA-22 in acute myocardial infarction[J].J Clin Lab Anal,2020,34(8):2410-2417.[10]Adachi T,Nakanishi M,Otsuka Y,et al.Plasma microRNA 499 as a biomarker of acute myocardial infarction[J].Clin Chem,2010,56(7):1183-1185.[11]Su T,Shao X,Zhang X,et al.Value of circulating miRNA-1 detected within 3h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction[J].Int J Cardiol,2020(307):146-151.[12]Yang J,Liu S,Wang H,et al.miR-134-5p inhibition reduces infarct-induced cardiomyocyte apoptosis via Creb1 upregulation[J].J Stroke Cerebrovasc Dis,2020,29(8):104850.[13]Ling H,Guo Z,Shi Y,et al.Serum Exosomal MicroRNA-21,MicroRNA-126,and PTEN Are Novel Biomarkers for Diagnosis of Acute Coronary Syndrome[J].Front Physiol,2020(11):654.[14]Gao C,Zhao D,Wang J,et al.Clinical significance and correlation of microRNA-21 expression and the neutrophil-lymphocyte ratio in patients with acute myocardial infarction[J].Clinics (Sao Paulo),2019(74):1237.[15]Dai Y,Yan T,Gao Y.Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction[J].Diagn Pathol,2020,15(1):19.[16]Guo X,Chen Y,Lu Y,et al.High level of circulating microRNA-142 is associated with acute myocardial infarction and reduced survival[J].Ir J Med Sci,2020,189(3):933-937.[17]Chen Z,Pan X,Yan G,et al.miR-142 is a Sensitive Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction[J].Clin Lab,2020(6):66.[18]Wang Y,Chang W,Zhang Y,et al.Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction[J].J Cell Physiol,2019,234(4):4778-4786.[19]Wang KJ,Zhao X,Liu YZ,et al.Circulating MiR-19b-3p,MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction[J].Cell Physiol Biochem,2016,38(3):1015-1029.[20]Li L,Li S,Wu M,et al.Early diagnostic value of circulating microRNAs in patients with suspected acute myocardial infarction[J].J Cell Physiol,2019,234(8):13649-13658.[21]Ali Sheikh MS.Overexpression of miR-375 Protects Cardiomyocyte Injury following Hypoxic-Reoxygenation Injury[J].Oxid Med Cell Longev,2020(2020):7164069.[22]Qiao GH,Zhu P,Yue L,et al.MiR-125b Improves acute myocardial infarction in rats by regulating P38/Sirtl/P53 signaling pathway[J].J Biol Regul Homeost Agents,2020,34(4):1297-1306.[23]Pinchi E,Frati P,Aromatario M,et al.miR-1,miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction[J].J Cell Mol Med,2019,23(9):6005-6016.[24]Thygesen K,Alpert JS,Jaffe AS,et al.Fourth Universal Definition of Myocardial Infarction (2018)[J].J Am Coll Cardiol,2018,72(18):2231-2264.[25]Lu Y,Thavarajah T,Gu W,et al.Impact of miRNA in Atherosclerosis[J].Arterioscler Thromb Vasc Biol,2018,38(9):159-170.[26]Otsuka M,Kishikawa T,Yoshikawa T,et al.MicroRNAs and liver disease[J].J Hum Genet,2017,62(1):75-80.[27]Meka IA,Anyim OB,Enebe JT,et al.Association of MiRNA122 & ADAM17 with Lipids among Hypertensives in Nigeria[J].Open Med (Wars),2018(13):350-358.[28]Iliopoulos D,Drosatos K,Hiyama Y,et al.MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism[J].J Lipid Res,2010,51(6):1513-1523.[29]Han QA,Su D,Shi C,et al.Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways[J].Food Funct,2020,11(4):3432-3440.[30]Zhu J,Liu B,Wang Z,et al.Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation[J].Theranostics,2019,9(23):6901-6919.[31]Duisters RF,Tijsen AJ,Schroen B,et al.miR-133 and miR-30 regulate connective tissue growth factor:implications for a role of microRNAs in myocardial matrix remodeling[J].Circ Res,2009,104(2):170-178.[32]Yang K,He YS,Wang XQ,et al.MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4[J].FEBS Lett,2011,585(6):854-860.[33]Loyer X,Potteaux S,Vion AC,et al.Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice[J].Circ Res,2014,114(3):434-443.[34]Son DJ,Kumar S,Takabe W,et al.The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis[J].Nat Commun,2013(4):3000.[35]Marchant DJ,Boyd JH,Lin DC,et al.Inflammation in myocardial diseases[J].Circ Res,2012,110(1):126-144.[36]Yan W,Abu-El-Rub E,Saravanan S,et al.Inflammation in myocardial injury:mesenchymal stem cells as potential immunomodulators[J].Am J Physiol Heart Circ Physiol,2019,317(2):213-225.[37]Hu G,Ma L,Dong F,et al.Inhibition of microRNA1243p protects against acute myocardial infarction by suppressing the apoptosis of cardiomyocytes[J].Mol Med Rep,2019,20(4):3379-3387.[38]Mir R,Elfaki I,Khullar N,et al.Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases,Including Coronary Artery Disease,Myocardial Infarction and Atherosclerosis[J].J Cardiovasc Dev Dis,2021,8(2):22.[39]Zou JF,Wu XN,Shi RH,et al.Inhibition of microRNA-184 reduces H2O2-mediated cardiomyocyte injury via targeting FBXO28[J].Eur Rev Med Pharmacol Sci,2020,24(21):11251-11258.[40]Chen Y,Yin Y,Jiang H.miR-30e-5p Alleviates Inflammation and Cardiac Dysfunction After Myocardial Infarction Through Targeting PTEN[J].Inflammation,2021,44(2):769-779.[41]Ma Y,Pan C,Tang X,et al.MicroRNA-200a represses myocardial infarction-related cell death and inflammation by targeting the Keap1/Nrf2 and β-catenin pathways[J].Hellenic J Cardiol,2021,62(2):139-148.[42]Kesidou D,da Costa Martins PA,de Windt LJ,et al.Extracellular Vesicle miRNAs in the Promotion of Cardiac Neovascularisation[J].Front Physiol,2020(11):1180.[43]Lew JK,Pearson JT,Saw E,et al.Exercise Regulates MicroRNAs to Preserve Coronary and Cardiac Function in the Diabetic Heart[J].Circ Res,2020,127(11):1384-1400.[44]Rawal S,Munasinghe PE,Shindikar A,et al.Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy[J].Cardiovasc Res,2017,113(1):90-101.[45]Moghaddam AS,Afshari JT,Esmaeili SA,et al.Cardioprotective microRNAs:Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease[J].Atherosclerosis,2019(285):1-9.[46]Fiedler J,Jazbutyte V,Kirchmaier BC,et al.MicroRNA-24 regulates vascularity after myocardial infarction[J].Circulation,2011,124(6):720-730.[47]González A,Schelbert EB,Díez J,et al.Myocardial Interstitial Fibrosis in Heart Failure:Biological and Translational Perspectives[J].J Am Coll Cardiol,2018,71(15):1696-1706.[48]Tian HB,Li SH,Hu KQ,et al.MicroRNA-150 alleviates acute myocardial infarction through regulating cardiac fibroblasts in ventricular remodeling[J].Eur Rev Med Pharmacol Sci,2019,23(17):7611-7618.
相似文献/References:
[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in
the Treatment of Acute Myocardial Infarction[J].Medical Information,2018,31(05):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Medical Information,2018,31(05):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者
心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Medical Information,2018,31(05):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[4]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并
心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Medical Information,2018,31(05):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[5]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(05):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[6]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(05):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[7]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(05):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[8]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,32(05):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[9]杨 震.急性心梗直接介入治疗术中慢血流及无复流的治疗进展[J].医学信息,2019,32(06):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
YANG Zhen.Progress in the Treatment of Slow Blood Flow and no Reflow in the Treatment of Acute Myocardial Infarction[J].Medical Information,2019,32(05):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
[10]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(05):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]